Summit Therapeutics Inc. (SMMT) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $92.32M | +97.2% |
| 2024 | $46.81M | -62.6% |
| 2023 | $125.26M | -76.7% |
| 2022 | $537.51M | +1686.4% |
| 2021 | $30.09M | +30.6% |
| 2020 | $23.05M | +32.6% |
| 2019 | $17.39M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $92.32M | +97.2% |
| 2024 | $46.81M | -62.6% |
| 2023 | $125.26M | -76.7% |
| 2022 | $537.51M | +1686.4% |
| 2021 | $30.09M | +30.6% |
| 2020 | $23.05M | +32.6% |
| 2019 | $17.39M | — |